miércoles, 25 de julio de 2018

From the lab - Extending Cancer Survival in Young Patients | NIH MedlinePlus the Magazine

From the lab - Extending Cancer Survival in Young Patients | NIH MedlinePlus the Magazine

NIH MedlinePlus Magazine

Extending Cancer Survival in Young Patients

Early results from a clinical trial show that a new drug may extend survival for cancer patients with a specific type of cancer. The cancer occurs in 1,000 people each year in the U.S. and often affects younger patients.
07/23/2018 11:57 AM EDT

From the National Institutes of Health
Related MedlinePlus Pages: Cancer in Children

No hay comentarios:

Publicar un comentario